OPRX
OptimizeRx Corp
Key Financials
Net Income
$5.1M
↑ 125.5%
Operating Income
$11.7M
↑ 185.3%
Gross Profit
$73.6M
↑ 23.9%
Revenue
$109.4M
↑ 18.8%
Total Assets
$176.9M
↑ 3.4%
EPS (Diluted)
$0.27
↑ 124.5%
Shareholders' Equity
$128.3M
↑ 9.7%
Cash & Equivalents
$23.4M
↑ 74.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/9/2026 | View on SEC |
| 8-K | 3/30/2026 | View on SEC |
| SCHEDULE 13G/A | 3/27/2026 | View on SEC |
| 10-K | 3/12/2026 | View on SEC |
| 8-K | 3/5/2026 | View on SEC |
| 4 | 2/13/2026 | View on SEC |
| 4/A | 12/23/2025 | View on SEC |
| 4 | 12/23/2025 | View on SEC |
| 4 | 12/23/2025 | View on SEC |
| 4 | 12/23/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | OPRX |
| Company Name | OptimizeRx Corp |
| CIK | 1448431 |
| Sector | Services-Business Services, NEC |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 7389 |
| SIC Description | Services-Business Services, NEC |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | NV |
| Phone | 248-651-6558 |